Our innovators

Welcome to
the Atrimed Plant Science Universe.

Atrimed is a critically acclaimed Biotech Pharma company with a difference. Its plant-based research provides holistic and side-effect-free cures to human illnesses. But what really sets it apart, is its firm belief in molecular testing and clinical trials. Atrimed was thus a pioneer in successfully combining the best practices of Plant Science and Allopathy into a verified science of medicine called Phytology.
It is this difference that gives it the edge over its competitors, setting it above and ahead of them in research and a wide product range that has stemmed from it. This has attracted the best scientists to it – healthcare and research professionals with extensive learning and experience in fields like phytochemistry and biotechnology – and scientists on a mission to see the world a healthier place.

Read More

Founders

Dr. Shiban Ganju
Founder and Chairman

View Detail

An AIIMS Delhi graduate certified by American Board of Internal Medicine and Gastroenterology, Dr Shiban Ganju has a large body of published work in scientific journals and his articles have appeared in Mail Today, 3Quarksdaily and The Seminar, among other publications. He has long been associated with public health, which has given him a deep insight into the unmet needs of the under-served market. He is the founder of ‘Save A Mother’, a healthcare NGO which has been working in 1500 Indian villages since 2008.
A string of formidable positions at various healthcare disciplines in India and USA have honed Dr Shiban’s lifelong dedication to the medical profession. Formerly a consultant at the University of Chicago Ingalls Hospital and Advocate Healthcare, Illinois, Dr Shiban was prior to that position, the CEO of Reliance Health & Technology, Director of Prakriya Hospitals, Adviser to Innovatio Curis Inc. and other organizations. He was also the founder of the Indo-American Medical Association, Illinois. Besides participating in policy making and various think tanks, he has also served in the Indian army.

Dr. Hrishikesh Damle
Founder and CEO

View Detail

A trained Ayurvedic physician with postgraduate degrees in plant pharmacology and clinical pharmacology, Dr. Hrishikesh Damle is a self-learner and an original thinker and very passionate about science. He quit his well-paying job to pursue his dream of new drug discovery from plant molecules. A team of bright scientists integrated advanced computing with an embedded AI system to cull knowledge from ancient medical practices and modern science hence a world class lab dedicated to avant grade plant science based medical innovations. His intuitive leadership, great management skills and entrepreneurship laced with professionalism has taken Atrimed across the globe.

Dr. Latha Damle
Chief Scientific Officer

View Detail

Dr. Latha Damle is the founder and Chief Scientific Officer at Atrimed. She is an Ayurvedic physician with a post-graduate degree in plant pharmacology and a fellowship in the field of medicinal chemistry at Toyama Medical and Pharmaceutical University Toyama, Japan. She has also acquired proficiency in chromatographic analysis which is the backbone of natural product research. With over 23 years of clinical experience, she understands the need for precision treatment.

Her research is propelled by her insight that therapeutic efficacy cannot be attributed to one molecule but to a combination of multiple complementary biomolecules, also known as Poly-pharmacology. She studies the biological activity of complementary molecules.

She has developed new methods for the extraction of unique chemicals from plants, their standardization, and the measurement of their presence in the final product. Dr. Latha, with her understanding of plant chemistry, knows that the time of collection of plant material and parts of the plants to be used for optimum extraction are of prime importance. With her background in clinical pharmacology and medicine, she has evaluated the efficacy of these Phyto-molecules against various diseases.
Dr. Latha has been an outstanding, meritorious student of ancient textbooks. Her dedication to keen observation, the pursuit of science, appetite for hard work, unbiased research, and meticulous documentation has contributed significantly to the growth of the unique products of Atrimed

Advisors

Narendra Chirmule

View Detail

Is it some kind of magic that a well-known Biotechnology professional who has immensely contributed to the development of vaccines and biologics and presented seminars on subjects of immunology, biologics and vaccines, is a great music connoisseur and enthusiast too? Well, Mr. Narendra Chirmule dons both the hats with great ease and effervescence.
His drug development experiences include Vaccines for cervical cancer [HPV], shingles [Varicella zoster], childhood diarrhoea [Rotavirus]), and Biologics for osteoporosis [Prolia], rheumatoid arthritis [Enbrel], platelet loss (NPlate) breast cancer (Ogrivi) among many others. He has worked on basic concepts of gene therapy using viral vectors.
He did his Ph.D. on the development of a leprosy vaccine, from Cancer Research Institute, Mumbai; post-doctoral studies on the pathogenesis of AIDS from Cornell University Medical College-North Shore Hospital, and taught immunology at the University of Pennsylvania.
He holds a Ph.D. from Cancer Research Institute, University of Mumbai, with post-doctoral training at Cornell University Medical College, and has teaching and research experience as an Assistant Professor in the Human Gene Therapy Group of the University of Pennsylvania.

Brands under Atrimed

Mahila by Atrimed – the only corporate healthcare chain for women in India – is incepted keeping in mind the welfare of women in our society with an integrated social outreach program for gynaecology, skincare, general diseases and early cancer detection. These clinics are trustworthy primary healthcare centres for women, operated by women healthcare professionals. The clinics provide integrated cutting-edge therapy and prevention with the help of both Ayurveda and Western medicines. All clinics function as an integral part of the community outreach through various health and wellness programs, especially those related to prevention, like early cancer detection in women.
Mahila is envisioned by the founders of Atrimed – Dr. Hrishikesh Damle, Dr. Shiban Ganju and Dr. Latha Damle – considering the plight of women with no attributed healthcare for them.

India got its freedom 72 years back but in this sleepy village in Amethi (UP), women were still living in the dark pre-independence era. They didn’t have access to education and good healthcare services. Infant and mother mortality rate during delivery was very high due to malnutrition and unsafe practices during child-birth. Tuberculosis was also a big contributor in rising death toll.
When Dr. Shibin saw their plight, he was deeply pained and decided to help them out. After giving it a lot of thought, he came up with Save A Mother – a foundation which educates women about self and family healthcare and nutrition, provides them with necessary medication, health check-ups and more. It substantially reduced mother infant mortality rate and deaths due to tuberculosis and brought the light of happiness in the life of villagers. It is a sustainable healthcare system for the poor. Taking this philosophy ahead, SAM has joined hands with Mahila to serve the women countrywide.

Company Updates

Atrimed Pharmaceuticals is a 15-year-old company located in Bangalore, India. We are growing rapidly with a sales network backed by effective products and strong R&D.

The Most Promising Biotech Companies in India

Atrimed Biotech: Traditional Knowledge, Modern Pharmaceutical Solutions :

Ancient India was a land of wisdom and is said to be much advanced than the civilization today is. Ayurveda or the system of medicine is just one of many advanced practices that were prevalent.

The most innovative biotech company

Atrimed Biotech: Working on Plant Molecules for Treatment of Psoriasis, Acne, and Arthritis by INSIGHTSCARE…
Science has reached a bottleneck in finding small molecules in therapeutics for many diseases. One drug, one disease, and one target are being strongly contemplated for its lethal side effects.